These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27741037)

  • 1. Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
    Vandenberghe F; Saigí-Morgui N; Delacrétaz A; Quteineh L; Crettol S; Ansermot N; Gholam-Rezaee M; von Gunten A; Conus P; Eap CB
    Pharmacogenet Genomics; 2016 Dec; 26(12):547-557. PubMed ID: 27741037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
    Vandenberghe F; Gholam-Rezaee M; Saigí-Morgui N; Delacrétaz A; Choong E; Solida-Tozzi A; Kolly S; Thonney J; Gallo SF; Hedjal A; Ambresin AE; von Gunten A; Conus P; Eap CB
    J Clin Psychiatry; 2015 Nov; 76(11):e1417-23. PubMed ID: 26646038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic risk scores with body mass index in Swiss psychiatric cohorts.
    Saigi-Morgui N; Vandenberghe F; Delacrétaz A; Quteineh L; Gholamrezaee M; Aubry JM; von Gunten A; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2016 May; 26(5):208-17. PubMed ID: 26918956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients.
    Delacrétaz A; Glatard A; Dubath C; Gholam-Rezaee M; Sanchez-Mut JV; Gräff J; von Gunten A; Conus P; Eap CB
    Clin Epigenetics; 2019 Dec; 11(1):198. PubMed ID: 31878957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
    Saigi-Morgui N; Quteineh L; Bochud PY; Crettol S; Kutalik Z; Wojtowicz A; Bibert S; Beckmann S; Mueller NJ; Binet I; van Delden C; Steiger J; Mohacsi P; Stirnimann G; Soccal PM; Pascual M; Eap CB;
    PLoS One; 2016; 11(10):e0164443. PubMed ID: 27788139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.
    Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP
    Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The physiopathology of weight regulation during treatment with psychotropic drugs].
    Kraus T; Zimmermann U; Schuld A; Haack M; Hinze-Selch D; Pollmächer T
    Fortschr Neurol Psychiatr; 2001 Mar; 69(3):116-37. PubMed ID: 11305122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population.
    Choong E; Bondolfi G; Etter M; Jermann F; Aubry JM; Bartolomei J; Gholam-Rezaee M; Eap CB
    J Psychiatr Res; 2012 Apr; 46(4):540-8. PubMed ID: 22316639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain.
    Vandenberghe F; Najar-Giroud A; Holzer L; Conus P; Eap CB; Ambresin AE
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):258-265. PubMed ID: 29297696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolution.
    Lenski M; Sidibé J; Gholam M; Hennart B; Dubath C; Augsburger M; von Gunten A; Conus P; Allorge D; Thomas A; Eap CB
    Clin Transl Sci; 2021 Nov; 14(6):2544-2555. PubMed ID: 34387942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.
    Pina-Camacho L; Díaz-Caneja CM; Saiz PA; Bobes J; Corripio I; Grasa E; Rodriguez-Jimenez R; Fernández M; Sanjuán J; García-López A; Tapia-Casellas C; Álvarez-Blázquez M; Fraguas D; Mitjans M; Arias B; Arango C
    Rev Psiquiatr Salud Ment; 2014; 7(4):166-78. PubMed ID: 25440735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Why getting fat, Doc?' Weight gain and psychotropic medications.
    Malhi GS; Mitchell PB; Caterson I
    Aust N Z J Psychiatry; 2001 Jun; 35(3):315-21. PubMed ID: 11437804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
    Dubath C; Gholam-Rezaee M; Sjaarda J; Levier A; Saigi-Morgui N; Delacrétaz A; Glatard A; Panczak R; Correll CU; Solida A; Plessen KJ; von Gunten A; Kutalik Z; Conus P; Eap CB
    Transl Psychiatry; 2021 Jun; 11(1):360. PubMed ID: 34226496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight changes in teens on psychotropic medication combinations at Austin State Hospital.
    Becker EA; Shafer A; Anderson R
    Tex Med; 2005 Mar; 101(3):62-70. PubMed ID: 16134805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients.
    Lim J; Ko YH; Joe SH; Han C; Lee MS; Yang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1918-21. PubMed ID: 21803114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
    Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study.
    Piras M; Ranjbar S; Laaboub N; Grosu C; Gamma F; Plessen KJ; von Gunten A; Conus P; Eap CB
    Schizophr Bull; 2023 Jan; 49(1):24-33. PubMed ID: 36156101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review.
    Khazaal Y; Chatton A; Rusca M; Preisig M; Zullino D
    Gen Hosp Psychiatry; 2007; 29(5):446-9. PubMed ID: 17888813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine treatment of psychotropic-induced weight gain in children and adolescents: case series.
    Gracious BL; Krysiak TE; Youngstrom EA
    J Child Adolesc Psychopharmacol; 2002; 12(3):249-57. PubMed ID: 12427299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.